Specific Binding of Liposomal Nanoparticles

  • ChemPubSoc Europe Logo
  • Author: Kate Lawrence
  • Published Date: 26 August 2017
  • Source / Publisher: ChemistryOpen/Wiley-VCH
  • Copyright: Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
thumbnail image: Specific Binding of Liposomal Nanoparticles

Related Societies

Radio-labeled liposomal pharmaceuticals are used for various diagnostic and therapeutic applications. Radiopharmaceuticals can passively accumulate within tumors by using the enhanced permeability and retention (EPR) effect. With increased accumulation, positron emission tomography (PET) can be used to delineate the tumor. Unfortunately, however, circulating liposomal nanoparticles tagged with long-lived radionucleotides, such as 89Zr and 64Cu, can deliver a large dose of radiation to non-targeted organs.

Thomas Reiner, Memorial Sloan Kettering Cancer Center, New York, USA, and colleagues have developed a method for the specific binding of liposomal radiopharmaceuticals to a CoCrMo alloy through an irreversible inverse electron-demand Diels–Alder (IEDDA) reaction. The team synthesized 89Zr-radiolabeled trans-cyclooctene (TCO)-functionalized liposomes. They then used a tetrazine-functionalized polydopamine-coated CoCrMo (Tz-PDA@CoCrMo) stent alloy to selectively remove them from the blood pool of tumor-bearing mice.

The specific binding between the two counterparts (pictured) through a rapid bioorthogonal IEDDA click reaction is a step towards a new technology for the on-demand removal of circulating liposomal nanoparticles in vivo. This could result in a systemic decrease in the radiotherapeutic dose deposited in healthy tissues and yield a larger therapeutic window, better treatment outcomes, and ultimately better prognoses.


Article Views: 1188

Sign in Area

Please sign in below

Additional Sign In options

Please note that to comment on an article you must be registered and logged in.
Registration is for free, you may already be registered to receive, e.g., the newsletter. When you register on this website, please ensure you view our terms and conditions. All comments are subject to moderation.

Article Comments - To add a comment please sign in

Bookmark and Share

If you would like to reuse any content, in print or online, from ChemistryViews.org, please contact us first for permission. more


ChemistryViews.org on Facebook

ChemistryViews.org on Twitter ChemistryViews.org on YouTube ChemistryViews.org on LinkedIn Sign up for our free newsletter

A product of ChemPubSoc Europe (16 European Chemical Societies)and Wiley-VCH